Companies / BOC Sciences / Onartuzumab
BOC Sciences

Onartuzumab | BOC Sciences

Onartuzumab is a humanized monoclonal antibody directed against the hepatocyte growth factor receptor (c-Met). c-Met is overexpressed on the cell surfaces of a variety of cancer cell types. Onartuzumab has been used in the research of non-small cell lung cancer.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.